|
||||||||||||||||
|
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule
What is HIPAA? back to top HIPAA is a federal law that was enacted in 1996 and created in response to concerns about the use and dissemination of PHI in an age when computers allow for easy access to and sharing of data. It defines how individuals will be informed of uses and disclosures of their medical information; sets forth the rights of individuals to access health information about them held by health-care providers; and mandates the establishment of privacy officers and boards, in addition to policies and procedures for data sharing. Under HIPAA the Department of Health and Human Services (DHHS) was obligated to create privacy regulations, known as the HIPAA Privacy Rule, which go into effect on April 14, 2003. The Privacy Rule protects the privacy of individually identifiable health information, such as medical history, diagnosis, treatment or payment information. Known as "protected health information" or PHI, this information also includes demographic information that is maintained with health information, e.g., an individual's date of birth and social security number. HIPAA protection applies to all forms of PHI both electronic and paper. Most research involving human subjects operates under the Common Rule (45 CFR part 46) and/or the Food and Drug Administration (FDA) human subject protection regulations (21 CFR Parts 50 and 56), which have some provisions that are similar to but separate from the HIPAA Privacy Rule research provisions. The Common Rule and FDA regulations, which apply to federally funded and some privately funded research, include protections to help ensure the privacy of subjects and confidentiality of information. The HIPAA Privacy Rule builds upon these existing Federal protections, creating a baseline of privacy protection for all individuals and their PHI. Each state's laws build on the HIPAA platform so that the higher standard will always prevail. Although HIPAA will present challenges to researchers who study health issues, Harvard's compliance efforts should be viewed as an opportunity to demonstrate to the public that scientists treat confidential information responsibly.
How the HIPAA Privacy Rule Affects Research at Harvard University back to top HIPAA regulations apply to individuals, organizations or institutions considered "covered entities." These include health care providers, health plans, and health care clearinghouses. In this context, health care providers include hospitals, physicians, and other caregivers, as well as researchers who work for covered entities and researchers who combine research with health care services, such as clinicians conducting clinical drug trials. The Privacy Rule does not apply directly to other researchers. Harvard University is not a covered entity under HIPAA. It is a "hybrid entity," consisting of both covered and non-covered components. The University's covered components include the University Health Service (UHS), the Dental School Dental Clinics, and the Harvard University Group Health Plan (HUGHP). All other parts of the University including researchers whose research involves health care information are not considered covered components. Our focus in this website is on how work processes and culture will change for you as faculty and researchers working within the non-covered components of the University, as distinct from Harvard-affiliated hospitals and those portions of the University deemed to be covered components under HIPAA. If you do not provide healthcare, your research data does not include PHI, and your research is not carried out at a covered entity, your work will not be affected by the HIPAA Privacy Rule. For excellent resources about HIPAA at Harvard-affiliated hospitals, see the HIPAA web pages of the Partners Healthcare System. For information about HIPAA, see the web pages of Risk Management and Audit Services
How will HIPAA Affect My Work? back to top Assuming that PHI does play a role in your research, the HIPAA Privacy Rule may affect several areas of your work life.
As a researcher seeking data, your first task is to find out if the data exist as PHI at a covered entity. If the entity holding the data is not a covered entity, then you do not need to concern yourself with the HIPAA Privacy Rule to obtain the data, unless the entity passes along secondary restrictions to you in disclosing the data. The pre-award sponsored research office that serves your school is available to help you obtain these data. If the data source is a covered entity, you should work with the covered entity's Privacy Officer for reliable information about the workings of HIPAA and to establish which of the permissible paths to access the PHI are available to you. Both your IRB office and pre-award sponsored research office are available to assist you. Pathways for Access to PHI from a Covered Entity back to top Activities preparatory to research Access to PHI through authorizations Access to PHI through an IRB Waiver under the HIPAA criteria Access to PHI through Limited Data Sets Access to PHI through De-identification of Data Sets
HIPAA and the NIH back to top The NIH is not involved in enforcing or monitoring compliance with the HIPAA Privacy Rule, but has published guidance, Impact of the HIPAA Privacy Rule on NIH Processes involving the Review, Funding and Progress Monitoring of Grants, Cooperative Agreements and Research Contracts . The NIH is developing educational materials for researchers, in collaboration with other DHHS research agencies. The HIPAA Privacy Rule may affect the feasibility, design, and cost of NIH-supported research. As the PHS 398 instructions indicate, you should discuss these issues, as needed, in the research plan and budget sections of the application. Some Requests for Applications (RFA) and Program Announcements (PA) soliciting applications for specific areas of research may require submission of a plan for acquiring or accessing data under HIPAA. In such cases, the review criteria listed in the RFA or PA could be augmented to include a discussion of the adequacy of such plans and reviewers would be asked to evaluate these. When reviewing progress, NIH will continue the practice of evaluating situations that significantly delay the study, change the study design or change the cost of the research. Bear in mind that significant delays, changes to, or increases in the cost of research requireprior approval of NIH. For general questions about how the HIPAA Privacy Rule may affect the review, funding, and progress monitoring of NIH grants, cooperative agreements, and research contracts, you should contact program and grants management staff at the NIH institutes relevant to your area of scientific interest.
Frequently Asked Questions back to top
Links for general information back to top
|
|||||||||||||||
|
Send your questions or comments about the web site to osr_webmaster@harvard.edu
|